Chromatin-mediated alternative splicing in reward pathophysiology
奖赏病理生理学中染色质介导的选择性剪接
基本信息
- 批准号:10188481
- 负责人:
- 金额:$ 48.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-15 至 2023-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAlternative SplicingBehaviorBrainBrain regionCell Culture SystemChromatinChronicDNADataData SetEngineeringEnzymesEpigenetic ProcessFunctional disorderGene ExpressionGene Expression RegulationGene TargetingGenesGenetic TranscriptionHistone H3HistonesLearningLysineMediatingMental DepressionMental disordersMethylationModificationMolecularMusNatureNeurobiologyNeuronsNuclearPathologyPharmaceutical PreparationsPost-Translational Protein ProcessingPrevalenceProtein IsoformsProteinsPublishingRNA SplicingRewardsRoleSelf AdministrationSpliced GenesStimulusStructureTestingVolitionWorkaddictionbrain reward regionschromatin modificationchromatin remodelingcocaine exposureepigenomegene functiongenome-wideinnovationinterdisciplinary approachlearned behaviormRNA Precursormotivated behaviornovel strategiesresponsetranscription factortranscriptome sequencing
项目摘要
PROJECT SUMMARY
The epigenome refers to covalent modifications of nuclear histone proteins and their
associated DNA, which function to regulate gene expression. There is a wealth of data
implicating epigenetic remodeling in neurobiological function and behavior, especially in the
context of reward pathologies, such as addiction and depression. However, due to the
promiscuity of the factors involved, previous studies have failed to distinguish between the mere
presence and the functional relevance of a given chromatin modification at a specific gene.
This limits the elucidation of the precise molecular mechanisms by which neuroepigenetic
remodeling regulates transcription. To address this, we utilize a multidisciplinary approach that
involves (1) analysis of chromatin immunoprecipiation (ChIP)- and RNA-sequencing (seq)
datasets from brain reward regions following volitional reward behavior and (2) direct
manipulation of such modifications, using an innovative strategy of gene-targeted epigenetic
editing using engineered transcription factors (ETFs).
The current proposal tests the hypothesis that histone posttranslational modifications
(HPTMs), specifically histone H3 lysine 36 methylation (H3K36me3), directly functions in
reward-mediated pre-mRNA alternative splicing. The rationale for this hypothesis includes
recently published data that both alternative splicing and H3K36me3 enrichment are highly
regulated by cocaine exposure, and our preliminary finding that there is a significant correlation
between genome-wide H3K36me3 enrichment and the splicing complexity of expressed
alternative isoforms. While chromatin-mediated alternative splicing is well established in cell-
culture systems, it has not yet been described as a mechanism in brain, despite the prevalence
of both widespread chromatin remodeling and alternative splicing in neurons. This proposal
outlines a novel strategy to demonstrate neuronal H3K36me3-mediated alternative splicing, and
the functional significance of this transcriptional mechanism to motivated behavior. In particular,
we will analyze neuronal changes in mouse brain reward regions following drug or natural
reward self-administration. This work will establish a strategy through which we can examine
additional mechanisms of chromatin-mediated alternative splicing in various brain regions,
expanding beyond the initial hypotheses of the current proposal.
项目摘要
表观基因组是指核组蛋白及其的共价修饰
相关的DNA,该DNA功能调节基因表达。有很多数据
暗示表观遗传重塑在神经生物学功能和行为中,尤其是在
奖励病理的背景,例如成瘾和抑郁。但是,由于
涉及因素的滥交,以前的研究未能区分
给定染色质修饰在特定基因上的存在和功能相关性。
这限制了神经概性的精确分子机制的阐明
重塑调节转录。为了解决这个问题,我们利用一种多学科的方法
涉及(1)分析染色质免疫沉淀(CHIP)和RNA-Sequist(SEQ)
自愿奖励行为和(2)直接来自大脑奖励区域的数据集
使用靶向基因的表观遗传学的创新策略来操纵这种修饰
使用工程转录因子(ETF)进行编辑。
当前的提案检验了组蛋白翻译后修饰的假设
(HPTMS),特别是组蛋白H3赖氨酸36甲基化(H3K36ME3),直接在
奖励介导的前MRNA替代剪接。该假设的理由包括
最近发布的数据,替代剪接和H3K36me3富集都很高
受可卡因暴露调节,我们的初步发现存在显着相关性
全基因组H3K36ME3富集与表达的剪接复杂性之间
替代同工型。虽然染色质介导的替代剪接在细胞中已经很好地确定
培养系统,尽管存在普遍存在,但尚未被描述为大脑中的一种机制
在神经元中的广泛染色质重塑和替代剪接的两种。这个建议
概述了一种新的策略,以证明神经元H3K36ME3介导的替代剪接,并且
这种转录机制对动机行为的功能意义。尤其,
我们将分析药物或天然后小鼠脑奖励区域的神经元变化
奖励自我管理。这项工作将建立一种我们可以检查的策略
染色质介导的替代剪接的其他机制在各个大脑区域,
扩展超出了当前建议的最初假设。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Single sample sequencing (S3EQ) of epigenome and transcriptome in nucleus accumbens.
伏隔核表观基因组和转录组的单样本测序 (S3EQ)。
- DOI:10.1016/j.jneumeth.2018.07.006
- 发表时间:2018
- 期刊:
- 影响因子:3
- 作者:Xu,SJ;Heller,EA
- 通讯作者:Heller,EA
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Elizabeth A Heller其他文献
Elizabeth A Heller的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Elizabeth A Heller', 18)}}的其他基金
Epigenetic regulation of Cdk5 in cognition and emotion
Cdk5在认知和情绪中的表观遗传调控
- 批准号:
10585391 - 财政年份:2023
- 资助金额:
$ 48.3万 - 项目类别:
Epigenetic mechanisms of sustained transcription across cocaine abstinence
可卡因戒断过程中持续转录的表观遗传机制
- 批准号:
10434147 - 财政年份:2021
- 资助金额:
$ 48.3万 - 项目类别:
Epigenetic mechanisms of sustained transcription across cocaine abstinence
可卡因戒断过程中持续转录的表观遗传机制
- 批准号:
10297955 - 财政年份:2021
- 资助金额:
$ 48.3万 - 项目类别:
Epigenetic mechanisms of sustained transcription across cocaine abstinence
可卡因戒断过程中持续转录的表观遗传机制
- 批准号:
10621891 - 财政年份:2021
- 资助金额:
$ 48.3万 - 项目类别:
In Vivo Gene-Specific Regulation Using Engineered ZFPs in Drug Abuse
在药物滥用中使用工程 ZFP 进行体内基因特异性调控
- 批准号:
8518823 - 财政年份:2013
- 资助金额:
$ 48.3万 - 项目类别:
In Vivo Gene-Specific Regulation Using Engineered ZFPs in Drug Abuse
在药物滥用中使用工程 ZFP 进行体内基因特异性调控
- 批准号:
8663073 - 财政年份:2013
- 资助金额:
$ 48.3万 - 项目类别:
相似国自然基金
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
- 批准号:82372743
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
MEK/ERK通路对Bim选择性剪接的调节及其在胃癌细胞对化疗敏感性中作用
- 批准号:81071809
- 批准年份:2010
- 资助金额:33.0 万元
- 项目类别:面上项目
Dyrk1A调控CaMKⅡδ的可变剪接及其在心脏重构过程中的作用
- 批准号:30971223
- 批准年份:2009
- 资助金额:31.0 万元
- 项目类别:面上项目
相似海外基金
Macrophage functional dynamics in adult heart regeneration
成人心脏再生中巨噬细胞的功能动态
- 批准号:
10658366 - 财政年份:2023
- 资助金额:
$ 48.3万 - 项目类别:
Using Human iPSC Models to Determine the Mechanism of Inflammation-Induced Disruption of Dopamine Neurotransmission
使用人类 iPSC 模型确定炎症引起的多巴胺神经传递中断的机制
- 批准号:
10575155 - 财政年份:2022
- 资助金额:
$ 48.3万 - 项目类别:
Isoform-dependent effects of tau phosphorylation in Alzheimer's disease
阿尔茨海默病中 tau 磷酸化的异构体依赖性效应
- 批准号:
10745286 - 财政年份:2022
- 资助金额:
$ 48.3万 - 项目类别:
Development of a brain penetrating single-chain antibody selectively targeting three repeat tau protein as a new treatment for frontotemporal dementia
开发选择性靶向三个重复 tau 蛋白的脑穿透单链抗体作为额颞叶痴呆的新治疗方法
- 批准号:
10383261 - 财政年份:2022
- 资助金额:
$ 48.3万 - 项目类别:
Using Human iPSC Models to Determine the Mechanism of Inflammation-Induced Disruption of Dopamine Neurotransmission
使用人类 iPSC 模型确定炎症引起的多巴胺神经传递中断的机制
- 批准号:
10707196 - 财政年份:2022
- 资助金额:
$ 48.3万 - 项目类别: